Page last updated: 2024-08-24

ibutilide and Auricular Flutter

ibutilide has been researched along with Auricular Flutter in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	24 (32.88)	18.2507
2000's	38 (52.05)	29.6817
2010's	8 (10.96)	24.3611
2020's	3 (4.11)	2.80

Authors

Authors	Studies
Buchanan, LV; Cimini, MG; Clark, MA; Emmert, DE; Gibson, JK; Glavanovich, MA; Hester, JB; Imbordino, RJ; LeMay, RJ; McMillan, MW; Perricone, SC; Squires, DM; Walters, RR	1
Cacioppo, F; Domanovits, H; Gupta, S; Herkner, H; Laggner, AN; Lutnik, M; Niederdoeckl, J; Oppenauer, J; Roth, D; Schnaubelt, S; Schuetz, N; Schwameis, M; Simon, A; Spiel, AO	1
Corp Dit Genti, V; Crijns, HJ; Koren, A; Kowey, PR; Naccarelli, GV; Reiffel, JA; Thind, M; Wieloch, M	1
Dasgupta, S; Dave, I; Fischbach, P; Whitehill, R	1
Ballard, DW; Lugovskaya, N; Nagam, MR; Reed, ME; Rome, AM; Stevenson, MD; Vinson, DR; Warton, EM	1
Ma, C; Xiang, M; Yang, Y; Yu, Z; Zhang, S	1
Agarwal, R; Bickford, CL; Durand, JB; Lenihan, DJ; Urbauer, DL	1
Ashwath, R; Prasad, D; Snyder, C	1
Hofmann, R; Hönig, S; Kammler, J; Kypta, A; Leisch, F; Schmitt, B; Steinwender, C	1
Benza, RL; Bourge, RC; Franco, V; Kirklin, JK; McGiffin, DC; Pamboukian, SV; Rayburn, BK; Smallfield, M; Tallaj, JA	1
Palma, EC; Zambito, PE	1
Guo, JH; Li, XY; Liu, P; Sun, JL; Yi, Z; Zhang, P	1
Antonatos, D; Babalis, D; Christou, A; Kafkas, N; Katsanos, S; Nikolaou, N; Patsilinakos, S; Spanodimos, S	1
Guo, J; Li, X; Liu, P; Sun, J; Zhang, P	1
Fragakis, N; Geleris, P; Koskinas, KC; Pagourelias, ED	1
Heidland, UE; Heintzen, MP; Hennersdorf, MG; Perings, C; Perings, SM; Strauer, BE; Zühlke, C	1
Kobayashi, Y	1
Cheng, J; Glatter, K; Lee, R; Scheinman, MM; Yang, Y; Zhang, S	1
Antonicelli, R; Recanatini, A; Testarmata, P	1
Chung, JO; Kalus, JS; Kenyon, KW; Kluger, J; Spencer, AP; Tsikouris, JP; White, CM; Ziska, M	1
Andò, G; Arrigo, F; Bramanti, O; Carerj, S; Di Rosa, S; Giannetto, M; Rizzo, F	1
Bettiol, F; Bisceglia, I; Fera, MS; Gaudio, C; Giovannini, E; Mazza, A; Pulignano, G; Tanzi, P	1
Aicher, F; Bachleitner, T; Eisserer, G; Gatterer, E; Grander, W; Heinze, G; Kühn, P; Lang, W; Niemeth, C; Reisinger, J; Siostrzonek, P; Vanicek, T	1
Chiladakis, JA; Kalogeropoulos, A; Manolis, AS; Patsouras, N	1
Bonso, A; Glatter, KA; Hongo, RH; Raviele, A; Rossillo, A; Scheinman, MM; Themistoclakis, S; Yang, Y	1
Delle Karth, G; Geppert, A; Gwechenberger, M; Haumer, M; Heinz, G; Meyer, B; Schillinger, M; Siostrzonek, P	1
Ammash, NM; Ballman, KV; Chandrasekaran, K; Friedman, PA; Gersh, BJ; Gurevitz, OT; Hammill, SC; Malouf, JF; Rosales, AG; White, RD	1
Guo, JH; Sun, JL; Zhang, HC; Zhang, N; Zhang, P	1
Doggrell, SA; Hancox, JC	1
Fang, Q; Ge, JB; Guo, JH; Guo, JX; Han, SM; Sun, YM; Wan, Z; Zhang, HC; Zheng, YA; Zhu, WQ	1
Dilaveris, P; Gialafos, E; Giannopoulos, G; Stefanadis, C; Synetos, A	1
Lynch, JJ; Regan, CP; Stump, GL; Wallace, AA	1
Fragakis, N; Katsaris, G; Kozirakis, M; Maligkos, G; Papadopoulos, N; Papanastasiou, S; Tsaritsaniotis, E	1
Scharf, C	1
McPherson, CA; Mountantonakis, SE; Moutzouris, DA; Papaioannou, GN; Tiu, RV	1
Chaveles, JI; Dagadaki, OK; Kafkas, NV; Kelesidis, KM; Mertzanos, GA; Papageorgiou, KI; Patsilinakos, SP	1
Burkart, TA; Conti, JB; Gonzalez, MD; Kron, J; Miles, WM	1
Balaji, S; Hoyer, AW	1
Coleman, CI; Kluger, J; Tercius, AJ; White, CM	1
Buchanan, LV; Gibson, JK; Kabell, GG; Turcotte, UM	1
Ellenbogen, KA; Guo, GB; Stambler, BS; Wood, MA	1
Ellenbogen, KA; Stambler, BS; Wood, MA	2
Ellenbogen, KA; Meissner, MC; Perry, KT; Sager, PT; Stambler, BS; Vanderlugt, JT; Wakefield, LK; Wesley, RC; Wood, MA; Zoble, RG	1
Roden, DM	1
Ellenbogen, KA; Perry, KT; Stambler, BS; VanderLugt, JT; Wakefield, LK; Wood, MA	1
Brunden, MN; Buchanan, LV; Gibson, JK; Hsu, CY; LeMay, RJ; Walters, RR	1
Pratt, CM; Waldo, AL	1
Gibson, JK; Lee, KS; Naccarelli, GV; VanderLugt, J	1
Clemo, HF; Ellenbogen, KA; Stambler, BS; VanderLugt, JT; Wood, MA	1
Kowey, PR; Luderer, JR; VanderLugt, JT	1
Kayser, SR	1
Foster, RH; Markham, A; Wilde, MI	1
Murray, KT	1
Carberry, PA; Dunn, GH; Kowey, PR; Lewis, WR; Perry, KT; Stambler, B; Vanderlugt, JT; Volgman, AS	1
Chang, MS; Chen, SA; Chen, YJ; Feng, AN; Tai, CT; Yu, WC	1
Camm, AJ; Obel, OA	1
Abi-Mansour, P; Carberry, PA; Dunn, GH; Henthorn, RW; McCowan, RJ; Perry, KT	1
Howard, PA	1
Golitsyn, SR; Harry, JD; Perry, KT; Ruda, MY; Stangl, K; Steinbeck, G; Touboul, P; Van Wijk, LV; Vos, MA; Wellens, HJ	1
Bala, MV; Calingaert, B; VanderLugt, JT; Zarkin, GA	1
Ahern, T; Denker, S; Kowey, PR; Mattioni, T; Perry, KT; Torchiana, D; VanderLugt, JT; Wakefield, LK	1
Hong, RA; Kaufman, LJ; Kofalvi, AE; Low, LL; Moreno-Cabral, CE	1
Guenette, AJ; Kaliebe, J; Murdock, DK; Olson, K; Schumock, GT	1
Sedighi, A; Varriale, P	1
Brunner, M; Domanovits, H; Janata, K; Laggner, AN; Nikfardjam, M; Schillinger, M; Thoennissen, J	1
Trohman, RG	1
Afshar, H; Khoshnevis, R; Massumi, A; Rasekh, A; Vaughn, WK; Zaqqa, M	1
Rogers, KC; Wolfe, DA	1
Chatterjee, K; Cheng, J; Glatter, K; Kayser, S; Modin, G; Scheinman, MM; Yang, Y	1
Donaldson, AR; Taylor, CT	1
Conti, CR; Eversole, A; Hancock, W; Johns, T; Lopez, LM	1
Brown-Mahoney, C; Ellenbogen, KA; Gilligan, DM; Nematzadeh, F; Stambler, BS; Wood, MA	1

Reviews

14 review(s) available for ibutilide and Auricular Flutter

Article	Year
[Current strategies of pharmacological and non-pharmacological treatment in atrial fibrillation and atrial flutter]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:7 Topics: Atrial Fibrillation; Atrial Flutter; Body Surface Potential Mapping; Catheter Ablation; Clinical Trials as Topic; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Pacemaker, Artificial; Piperazines; Sulfonamides	2002
Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert opinion on investigational drugs, 2005, Volume: 14, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Sulfonamides	2005
[Atrial flutter and fibrillation]. Praxis, 2005, Nov-09, Volume: 94, Issue:45 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents	2005
Electrophysiology and pharmacology of ibutilide. The American journal of cardiology, 1996, Oct-17, Volume: 78, Issue:8A Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrophysiology; Half-Life; Heart Conduction System; Humans; Sulfonamides	1996
Efficacy of ibutilide for termination of atrial fibrillation and flutter. The American journal of cardiology, 1996, Oct-17, Volume: 78, Issue:8A Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Electrocardiography; Humans; Sulfonamides	1996
Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter. The American journal of cardiology, 1996, Oct-17, Volume: 78, Issue:8A Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Electric Countershock; Electrocardiography; Humans; Risk Factors; Safety; Sulfonamides	1996
Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation. Drugs, 1997, Volume: 54, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Sulfonamides	1997
Ibutilide. Circulation, 1998, Feb-10, Volume: 97, Issue:5 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Sulfonamides	1998
The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide. Drugs & aging, 1998, Volume: 12, Issue:6 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Sulfonamides; Treatment Outcome	1998
Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; MEDLINE; Sulfonamides	1999
Cardioversion of atrial fibrillation with ibutilide in an orthotopic heart transplant patient. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:10 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Female; Heart Transplantation; Humans; Infusions, Intravenous; Middle Aged; Postoperative Complications; Sulfonamides	1999
Supraventricular tachycardia: implications for the intensivist. Critical care medicine, 2000, Volume: 28, Issue:10 Suppl Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil; Wolff-Parkinson-White Syndrome	2000
Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter. The Journal of emergency medicine, 2001, Volume: 20, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Injections, Intravenous; Patient Selection; Sulfonamides; Time Factors	2001
Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide. American heart journal, 2002, Volume: 143, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Drug Interactions; Electrocardiography; Female; Humans; Male; Polypharmacy; Retrospective Studies; Sulfonamides; Tachycardia, Ventricular	2002

Trials

26 trial(s) available for ibutilide and Auricular Flutter

Article	Year
[Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2013, Volume: 42, Issue:2 Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Female; Humans; Male; Middle Aged; Propafenone; Sulfonamides; Treatment Outcome; Young Adult	2013
Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter. International journal of cardiology, 2010, Jun-11, Volume: 141, Issue:3 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Synergism; Electrocardiography; Female; Heart Conduction System; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Placebo Effect; Prospective Studies; Sulfonamides; Treatment Outcome	2010
Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent. The American journal of cardiology, 2010, Sep-01, Volume: 106, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Torsades de Pointes; Treatment Outcome	2010
Electrophysiological response of the right atrium to ibutilide during typical atrial flutter. Circulation, 2002, Aug-13, Volume: 106, Issue:7 Topics: Adult; Aged; Atrial Flutter; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Atria; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Sulfonamides	2002
Ibutilide in rapid conversion of atrial flutter in octogenarians. Drugs & aging, 2002, Volume: 19, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Sulfonamides; Treatment Outcome	2002
Efficacy and safety of ibutilide vs. transoesophageal atrial pacing for the termination of type I atrial flutter. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2004, Volume: 6, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Female; Humans; Male; Middle Aged; Sulfonamides; Treatment Outcome	2004
Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. European heart journal, 2004, Volume: 25, Issue:15 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Female; Flecainide; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Single-Blind Method; Sulfonamides	2004
Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. Journal of the American College of Cardiology, 2004, Aug-18, Volume: 44, Issue:4 Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome	2004
Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. Journal of the American College of Cardiology, 2004, Aug-18, Volume: 44, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Italy; Male; Middle Aged; Propafenone; Prospective Studies; San Francisco; Sulfonamides; Treatment Outcome	2004
Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population. Wiener klinische Wochenschrift, 2005, Volume: 117, Issue:3 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Austria; Critical Care; Female; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sulfonamides; Treatment Outcome	2005
Clinical comparison of ibutilide and propafenone for converting atrial flutter. Cardiovascular drugs and therapy, 2005, Volume: 19, Issue:1 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Time Factors; Treatment Outcome	2005
[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study]. Zhonghua yi xue za zhi, 2005, Mar-30, Volume: 85, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Single-Blind Method; Sulfonamides; Treatment Outcome	2005
Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter. The American journal of emergency medicine, 2006, Volume: 24, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Emergency Service, Hospital; Female; Hospitals, Community; Humans; Hypotension; Infusions, Intravenous; Length of Stay; Male; Metoprolol; Prospective Studies; Sulfonamides	2006
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. International journal of cardiology, 2007, Jun-12, Volume: 118, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Recurrence; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Treatment Outcome	2007
Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter. Pacing and clinical electrophysiology : PACE, 2007, Volume: 30, Issue:11 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Electrocardiography; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Treatment Outcome	2007
Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability. Journal of the American College of Cardiology, 1996, Volume: 27, Issue:5 Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Sulfonamides	1996
Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. The American journal of cardiology, 1996, May-01, Volume: 77, Issue:11 Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Double-Blind Method; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Procainamide; Sulfonamides; Treatment Outcome	1996
Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. Journal of the American College of Cardiology, 1996, Volume: 28, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Tachycardia, Ventricular; Time Factors	1996
Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation, 1996, Oct-01, Volume: 94, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Forecasting; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome	1996
Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation, 1997, Dec-16, Volume: 96, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrophysiology; Female; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Sulfonamides; Treatment Outcome	1997
Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. Journal of the American College of Cardiology, 1998, Volume: 31, Issue:6 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Electric Countershock; Female; Humans; Male; Procainamide; Prospective Studies; Sulfonamides; Treatment Outcome	1998
Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. American heart journal, 1998, Volume: 136, Issue:4 Pt 1 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Missouri; Sulfonamides; Treatment Outcome	1998
Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart (British Cardiac Society), 1998, Volume: 79, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sotalol; Sulfonamides; Time Factors	1998
The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. The American journal of managed care, 1997, Volume: 3, Issue:9 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Double-Blind Method; Electric Countershock; Health Resources; Humans; Placebos; Sulfonamides; Technology Assessment, Biomedical	1997
Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation, 1999, Jul-27, Volume: 100, Issue:4 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Postoperative Complications; Sulfonamides; Tachycardia, Ventricular	1999
Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter. The American journal of cardiology, 2000, Feb-15, Volume: 85, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Electric Countershock; Electrocardiography; Female; Heart Rate; Hospital Costs; Humans; Injections, Intravenous; Male; Medicare; Sulfonamides; Treatment Outcome; United States	2000

Other Studies

33 other study(ies) available for ibutilide and Auricular Flutter

Article	Year
Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential. Journal of medicinal chemistry, 2001, Mar-29, Volume: 44, Issue:7 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Dogs; Humans; In Vitro Techniques; Male; Microsomes, Liver; Rabbits; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Tachycardia, Ventricular	2001
Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study. International journal of environmental research and public health, 2022, 05-28, Volume: 19, Issue:11 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Electric Countershock; Humans; Registries; Sulfonamides; Tachycardia; Treatment Outcome	2022
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials. Journal of cardiovascular electrophysiology, 2020, Volume: 31, Issue:5 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials, Phase III as Topic; Dronedarone; Electric Countershock; Europe; Female; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Retreatment; Risk Assessment; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome; United States	2020
Chemical cardioversion of atrial flutter and fibrillation in the pediatric population with Ibutilide. Pacing and clinical electrophysiology : PACE, 2020, Volume: 43, Issue:3 Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Sulfonamides; Young Adult	2020
Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of emergency medicine, 2018, Volume: 71, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Patient Selection; Retrospective Studies; Sulfonamides; Treatment Outcome; Young Adult	2018
Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients. The American journal of the medical sciences, 2014, Volume: 347, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Sulfonamides	2014
Ibutilide therapy in the conversion of atrial flutter in neonates. Heart rhythm, 2013, Volume: 10, Issue:8 Topics: Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Female; Humans; Infant, Newborn; Male; Sulfonamides; Treatment Outcome	2013
Safety and efficacy of ibutilide in heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:5 Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Block; Biopsy; Electrocardiography; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Postoperative Complications; Sulfonamides; Tachycardia, Supraventricular; Treatment Outcome	2009
2:1 left to right interatrial block and other effects of ibutilide during non-isthmus-dependent atrial flutter. Pacing and clinical electrophysiology : PACE, 2009, Volume: 32, Issue:10 Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Heart Block; Humans; Male; Sulfonamides	2009
[The study of inhibiting heart rate and rapidly terminating atrial flutter of ibutilide on canine]. Zhonghua xin xue guan bing za zhi, 2009, Volume: 37, Issue:10 Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Dogs; Heart Rate; Male; Sulfonamides	2009
Effects of ibutilide on inhibiting heart rate and rapidly terminating atrial flutter in canine. Cell biochemistry and biophysics, 2011, Volume: 59, Issue:3 Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Dogs; Electrodes; Electrophysiology; Heart Rate; Male; Sulfonamides	2011
Brugada syndrome masked by ibutilide treatment in a patient with atrial flutter. Cardiology, 2012, Volume: 122, Issue:2 Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Flutter; Brugada Syndrome; Electrocardiography; Humans; Male; Sulfonamides	2012
Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Intensive care medicine, 2002, Volume: 28, Issue:7 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Critical Care; Electric Countershock; Electrocardiography; Germany; Humans; Intensive Care Units; Middle Aged; Sulfonamides; Treatment Outcome	2002
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chemoprevention; Cohort Studies; Drug Synergism; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Sulfonamides; Treatment Outcome	2003
Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias. Minerva cardioangiologica, 2004, Volume: 52, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Flutter; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Sulfonamides; Time Factors	2004
Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter. American heart journal, 2005, Volume: 149, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Premedication; Sulfonamides	2005
Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2005, Volume: 10, Issue:3 Topics: Aged; Algorithms; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Humans; Male; Pilot Projects; Sulfonamides; Treatment Outcome	2005
In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3 Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Dogs; Electrocardiography; Electrophysiology; Female; Kv1.5 Potassium Channel; Male; Phosphines; Potassium Channel Blockers; Propafenone; Sulfonamides	2005
Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone. Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:9 Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome	2005
Successful termination of atrial flutter by ibutilide during pregnancy. Pacing and clinical electrophysiology : PACE, 2007, Volume: 30, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Flutter; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Sulfonamides; Treatment Outcome	2007
The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing and clinical electrophysiology : PACE, 2007, Volume: 30, Issue:8 Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Female; Heart Defects, Congenital; Humans; Infant; Male; Pacemaker, Artificial; Sulfonamides; Treatment Outcome	2007
Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter. Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:1 Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Chronic Disease; Disease Models, Animal; Dogs; Male; Physical Conditioning, Animal; Rest; Sulfonamides	1993
Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians. Circulation, 1996, Oct-01, Volume: 94, Issue:7 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Approval; Humans; Sulfonamides; United States; United States Food and Drug Administration	1996
Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. Journal of cardiovascular electrophysiology, 1996, Volume: 7, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Cross-Over Studies; Dogs; Electrocardiography; Infusions, Intravenous; Male; Pericarditis; Sotalol; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry	1996
Introduction: acute treatment of atrial fibrillation and flutter--ibutilide in perspective. The American journal of cardiology, 1996, Oct-17, Volume: 78, Issue:8A Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Sulfonamides	1996
Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter. Progress in cardiovascular nursing, 1997,Winter, Volume: 12, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Sulfonamides	1997
Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination. Circulation, 1998, May-19, Volume: 97, Issue:19 Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Cardiac Catheterization; Electrophysiology; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Sulfonamides	1998
Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Clinical cardiology, 2000, Volume: 23, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Care Units; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Secondary Prevention; Sulfonamides; Treatment Outcome	2000
Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion. Resuscitation, 2000, Aug-01, Volume: 45, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Emergency Service, Hospital; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Sulfonamides; Treatment Outcome	2000
Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter. The American journal of cardiology, 2000, Jan-01, Volume: 85, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Heart Rate; Humans; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome	2000
Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation, 2001, Jan-16, Volume: 103, Issue:2 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Sulfonamides; Torsades de Pointes	2001
Safety and effectiveness of ibutilide in a community hospital. Pharmacotherapy, 2001, Volume: 21, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Hospitals, Community; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides	2001
Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice. Clinical cardiology, 2001, Volume: 24, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Safety; Sulfonamides	2001